Center for Cancer and Blood Disorders

Washington D.C., District of Columbia 20010-2970

0 studies enrolling now · 1 studies all time

What they study most

Hemolytic Anemia, Iron Overload, Sickle Cell Disease

Studies at this site

• Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients — Completed